Insights
My summer internship at Symmetron
A health economics analyst shares his experience of undertaking an internship at Symmetron, by answering some commonly asked questions.
HEOR Glossary
Do you often read HEOR-related content? Do you want to gain further insight on specific technical terms?
Whether you are just starting your career in HEOR or are a seasoned consultant, read and bookmark our latest glossary. It contains a wide range of terms to help you grasp complex concepts.
A cloud computing solution for improving the run-time of individual patient simulation models
What's the longest time you left a health economic model running to complete a probabilistic analysis of 1,000 simulations? One of our senior health economists won our internal competition with a wild 5.5 days! In an effort to improve the significant simulation...
Unmet medical need and market access: enabler or barrier to innovation?
Designed to help healthcare stakeholders identify more urgent health needs, the concept of “unmet medical need” is being increasingly applied formally and informally to set priorities during the development, assessment, and reimbursement of new drugs and medical...
What is qualitative evidence synthesis?
Evidence synthesis aggregates all relevant information on a specific topic in order to draw well-informed, evidence-based decisions. It is an essential activity in recommending, providing and evaluating clinical care. If improperly done, however, evidence synthesis...
Market access: budget impact analysis
What is a budget impact anaylsis? Pressure on healthcare insurers to fund the best available care while keeping within budgetary constraints has made budget impact analysis (BIA) an increasingly important part of any application for getting new drugs or medical...
When is a simple model enough? How to handle structural uncertainty in cost-effectiveness models.
Sam Bryning, intern at Symmetron: ‘formally accounting for structural uncertainty in cost-effectiveness models makes research and decision making more robust’. Cost-effectiveness models in healthcare attempt to capture the main features of clinical pathways that are...
Health economic modelling: a guide for pharmaceutical and medical device companies
Health economic modelling is a process for synthesising and comparing the costs and benefits of new (proposed) and existing medicines or devices in order to make decisions about which interventions may lead to the best patient outcomes. It is a key component of the...
Evidence generation and communication in drug development
Clinical evidence generation: clinical trials Health researchers continually discover new evidence that deepens our understanding of disease processes and progression. This rapidly evolving knowledge must be integrated into ongoing research and development of new...
Evidence synthesis for healthcare decision-making
What is evidence synthesis? As the pharmaceutical market rapidly evolves to keep pace with patient needs and emerging research, healthcare decision makers must continuously re-evaluate the evidence base that informs their thinking. But how can they take into account...